Human IgM antibody therapy for HIV-1 infection. - Wikidata - wikimedia - TriplyDB

Human IgM antibody therapy for HIV-1 infection.

Human IgM antibody therapy for HIV-1 infection.

http://www.wikidata.org/entity/Q33753260

about

Diagnostic surface expression of SWAP-70 on HIV-1 infected T cells.

P2860

Q33237009-7856A5F9-16FB-4723-A5B8-C87B048CF6DB

P2860

Human IgM antibody therapy for HIV-1 infection.

http://www.wikidata.org/entity/Q33753260

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Human IgM antibody therapy for HIV-1 infection.

@ast

Human IgM antibody therapy for HIV-1 infection.

@en

type

label

Human IgM antibody therapy for HIV-1 infection.

@ast

Human IgM antibody therapy for HIV-1 infection.

@en

prefLabel

Human IgM antibody therapy for HIV-1 infection.

@ast

Human IgM antibody therapy for HIV-1 infection.

@en

P1433

Q33753260-31A12354-D0F4-466C-B24E-995DE1A49C24

P1476

Q33753260-32567CC0-E912-4319-8D65-456A71FD425E

P2093

Q33753260-4F407975-A24A-4617-843C-BD469B6173CB

Q33753260-E966E727-376A-4C50-BE4C-791B321EC37F

P2860

Q33753260-0101F945-94E1-432F-8A2E-0F41FE1EEEE4

Q33753260-02C415D7-2628-4F2F-AE9E-82BA4BF35F2B

Q33753260-1517A844-9B24-4F56-9CBB-BD60E552277B

Q33753260-302D599B-A9F6-4D8C-87FB-4F6DA3D66070

Q33753260-41BD0362-BB8F-40B1-9517-E142E3AEDA5A

Q33753260-461D7EE4-4663-40C6-9D09-0D1CCA1C6D60

Q33753260-467EC0E3-29B2-42E7-8155-AAA2532163CC

Q33753260-53655C73-4812-4E7E-ABD9-1CC51F060134

Q33753260-5C8614DD-8DEF-4724-AC96-4B069CBAED6D

Q33753260-616C72F1-DB66-4B5B-984D-6618E524A7C9

P304

Q33753260-90C21CA7-A1DF-42B3-AEA7-4DF54B46714B

P31

Q33753260-EAD93D79-4043-4D94-BD45-8245C997F4D9

P356

Q33753260-B50DCA67-FFFA-4C76-9AB1-6D60FE4A5988

P433

Q33753260-A6F62896-D53C-49B3-A165-DA78E7D20C90

P478

Q33753260-2DF1D7D4-63CB-482E-9BC8-0859568C0090

P577

Q33753260-7A7C28AD-FAE4-4C30-A652-F35F83F1D7CB

P5875

Q33753260-C9045781-D8D9-4277-A8FE-649FBD99E13A

P698

Q33753260-541C2359-7043-4EF8-A00F-F0C7664B3490

P356

J.1348-0421.1999.TB02463.X

P1433

Microbiology and Immunology

P1476

Human IgM antibody therapy for HIV-1 infection.

@en

P2093

Okada H

http://www.w3.org/2001/XMLSchema#string

Okada N

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Human IgM monoclonal antibody to ganglioside GM2 and complement suppress virus propagation in ex vivo cultures of lymphocytes from HIV-1 infected patients

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

Decay characteristics of HIV-1-infected compartments during combination therapy

Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.

Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.

GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax.

Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines

The control of homologous lysis.

Ganglioside GM2 as a human tumor antigen (OFA-I-1).

P304

729-736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1348-0421.1999.TB02463.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12775353

http://www.w3.org/2001/XMLSchema#string

P698

10524789

http://www.w3.org/2001/XMLSchema#string